Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial-Reference-Cited by-同舟云学术

Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial

Published:2019-02-22 Issue:5 Volume:21 Page:1177-1190
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Ruggenenti Piero¹²,Trillini Matias¹,P. Barlovic Drazenka³,Cortinovis Monica¹,Pisani Antonio⁴,Parvanova Aneliya¹,Iliev Ilian P.¹,Ruggiero Barbara¹,Rota Stefano²,Aparicio Maria C.¹,Perna Annalisa¹,Peraro Francesco¹,Diadei Olimpia¹,Gaspari Flavio¹,Carrara Fabiola¹,Stucchi Nadia¹,Martinetti Davide¹,Janez Andrej³,Gregoric Nadan³,Riccio Eleonora⁴,Bossi Antonio C.⁵,Trevisan Roberto⁶,Manunta Paolo⁷,Battaglia Giovanni⁸,David Salvatore⁹,Aucella Filippo¹⁰,Belviso Antonio¹¹,Satta Andrea¹²,Remuzzi Giuseppe¹¹³^ORCID,

Affiliation:

1. Department of Renal MedicineClinical Research Centre for Rare Diseases “Aldo e Cele Daccò”: Istituto di Ricerche Farmacologiche Mario Negri IRCCS Ranica (Bergamo) Italy

2. Unit of Nephrology and DialysisAzienda Socio‐Sanitaria Territoriale Papa Giovanni XXIII Bergamo Italy

3. Clinical Department of EndocrinologyDiabetes and Metabolic Diseases University Medical Centre Ljubljana Ljubljana Slovenia

4. Chair of Nephrology, Department of Public HealthFederico II University of Naples Naples Italy

5. Unit of Diabetology and Metabolic DiseasesAzienda Socio‐Sanitaria Territoriale Bergamo Ovest Treviglio‐Caravaggio‐Romano (Bergamo) Italy

6. Unit of Diabetology and EndocrinologyAzienda Socio‐Sanitaria Territoriale Papa Giovanni XXIII Bergamo Italy

7. Chair of Nephrology, Genomics of Renal Diseases and Hypertension Unit, IRCCS San Raffaele Scientific Institute‐Chair of NephrologyUniversità Vita Salute San Raffaele Milan Italy

8. Department of Nephrology and DialysisHospital “S. Marta e S. Venera” Acireale (Catania) Italy

9. Department of Nephrology and DialysisHospital “Azienda Ospedaliera di Parma” Parma Italy

10. Department of Nephrology and Dialysis, Research Hospital “Casa Sollievo della Sofferenza” San Giovanni Rotondo (Foggia) Italy

11. Poliambulatorio Extra‐ospedalieroASST Bergamo Ovest Brembate di Sopra (Bergamo) Italy

12. Institute of Medical PathologyUniversity AUSL 1 Sassari Italy

13. L. Sacco, Department of Biomedical and Clinical ScienceUniversity of Milan Milan Italy

Funder

The Italian Medicines Agency

Novartis Italia

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13639

Reference31 articles.

1. Diabetic Kidney Disease: A Report From an ADA Consensus Conference

2. United States Renal Data System:USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States Bethesda MD:National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases;2015.

3. Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014

4. Nephropathy in Patients with Type 2 Diabetes

5. Economic Costs of Diabetes in the U.S. in 2017

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of dual renin–angiotensin system (RAS) blockade for non-elderly diabetic kidney disease patients with preserved eGFR;International Urology and Nephrology;2024-07-17

2. Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease;Cochrane Database of Systematic Reviews;2024-04-29

3. Secular Trend in GFR Decline in Non-Dialysis CKD Based on Observational Data From Standard of Care Arms of Trials;American Journal of Kidney Diseases;2023-11

4. Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM);Journal of the American Society of Nephrology;2023-08-10

5. The association between dual RAAS inhibition and risk of acute kidney injury and hyperkalemia in patients with diabetic kidney disease: a systematic review and meta-analysis;Nephrology Dialysis Transplantation;2023-06-12